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ABSTRACT
Antibodies raised in rabbits to Triton-solubilized, purified acetylcholine receptor
from Torpedocalfornica were used to immunospecifically label intact T. californica
electroplaque membrane vesicles attached to cover slips and oriented with the
extracellular face of the synaptic membrane facing outward. Hemocyanin conju-
gated to Protein A was then used as a marker, making the antibody binding visible
at the electron microscope level . Parallel labeling experiments were performed on
vesicles attached to cover slips and sheared by sonication, leaving their cytoplasmic
faces fully exposed to the labeling solution . While differences in antibody popu-
lations among different rabbits were observed, antigenic determinants of the
receptor were present on both faces of the membrane, with those on the extracel-
lular side more numerous than those on the cytoplasmic side, demonstrating the
transmembrane nature of the receptor molecule .
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Membrane fragments containing up to 50% of
their total protein as acetylcholine receptor
(AcChR)' can be isolated from the electric organs
of Torpedo californica (6, 8) . Such membrane frag-
ments have most, if not all, of the molecular
'Abbreviations used in thispaper: AcChR, acetylcholine
receptor; a-BuTx, a-bungarotoxin ;EAMG, experimental
autoimmune myasthenia gravis; Hcy/A, hemocyanin-
Protein A conjugate ; Ig, immunoglobulin ; MFTS, Tri-
ton-solubilized membrane fragment proteins; MFTS-R,
Triton-solubilized membrane fragment proteins depleted
in AcChR; NPE buffer, 10 mM Na-phosphate, 0.4 M
NaCl, 1 mM EDTA, pH 7.4 ; NRG, pre-immune rabbit
Ig .
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properties of the postsynaptic membrane of the
electroplaques; they bind a-neurotoxins (6, 8) and
cholinergic ligands (27, 41) at structurally related
sites and possess distinct binding sites for local
anesthetics (7, 34, 41) and the alkaloid histrioni-
cotoxin (10, 11) . Cholinergic agonists binding to
the AcChR cause the flux of inorganic cations
through the membrane (4, 13, 17, 23), suggesting
that the AcChR is all or part of a transmembrane
complex . The question of the disposition of the
AcChR molecule in the membrane, however, re-
mains a controversial issue .
When examined at the electron microscope
level, AcChR-enriched membrane fragments are
observed to be mostly in the form of vesicles, with
densely packed cylindrical rosettes 60-80 A in
diameter (3, 24, 28) that become more prevalent
499as the membrane preparations become more en-
riched in AcChR . Negative staining of Triton-
solubilized purified AcChR reveals these same
rosettes (3, 9, 32, 38) . This correlation of the
presence ofthe rosettes and that of theAcChR, as
well as the recent immunospecific labeling ofneg-
atively stained membrane fragments with antibod-
ies to AcChR by Klymkowsky and Stroud (18),
has led to the identification ofthis rosette structure
as the AcChR molecule . X-ray diffraction studies
of AcChR-enriched T . californicamembrane frag-
ments by Ross et al. (32) have shown that the
protein present spanned the membrane, extending
55 A on one side of the bilayer and 15 A on the
other. Likewise, Rash et al . (30) observed trans-
membrane staining with OSO4/K3Fe(CN) 6 of the
protein at mammalian neuromuscular junctions
and in membrane preparations from Torpedo os-
cellata and correlated this with anti-AcChR anti-
body binding they observed on one side of these
same membranes . In studies ofvisualization of the
binding of ferritin-conjugated anti-AcChR anti-
bodies to Torpedo membrane vesicles by electron
microscopy of thin sections, Karlin et al. (15)
found antibody binding to the outside surface of
the vesicles with some labeling on the inside sur-
face which they were unable to distinguish from
nonspecific trapping that occurred . Using the same
experimental approach, Tarrab-Hazdai et al. (40)
observed some binding of anti-AcChR antibodies
to both sides of the membrane of some open
vesicles as evidence that the receptor spans the
membrane .
A major problem in these studies has been in
ascertaining the accessibility of both sides of the
membrane to the antibody molecules . The recent
isolation of intact, outside-out receptor-containing
membrane vesicles provides a method for deter-
mining which side of the electroplaque synaptic
membrane (cytoplasmic or extracellular) corre-
sponds to which side of the isolated membrane
vesicles being labeled in such studies (12) . We
report here the use of such intact vesicles with
their extracellular faces exposed for immunospe-
cific labeling of the AcChR molecule . In further
studies the vesicles were sheared, exposing their
cytoplasmic faces to the immunospecific labeling
reagents and providing a well-defined preparation
for determining the transmembrane nature of the
AcChR .
MATERIALS AND METHODS
Crude membrane fragments were prepared from T . californica
electroplax by the method of Reed et al. (31) . Purified AcChR,
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solubilized in Triton, was prepared from crudemembrane frag-
ments according to Schmidt and Raftery using affinity chroma-
tography (35) . Intact, right-side out vesicles enriched in AcChR
(0 .5-1 .5 nmol a-bungarotoxin (a-BuTx) sites per mg of total
protein) were made in 10mM Na-phosphate, 0.4MNaCl, 1mM
EDTA, pH 7.4 (NPE buffer) (12) . Briefly, crude membrane
fragments were prepared in isotonic buffer and were then frac-
tionated on a 4-20% sucrose gradient at 195,700 g for 1 h . The
osmotically intact AcChR-enriched vesicles banded at the top of
thegradient. The sidedness ofthe vesicles was determined by the
a-BuTx sites assay described by Hartig and Raftery (12). Intact
vesicles were first incubated with an excess of "'I-a-BuTx pre-
pared by the method of Clark et al. (4) and Blanchard et al. (1),
in NPE. After 30 min, identical aliquots were diluted into (a) 10
mM Na-phosphate, 50 mM NaCl, 0.1% Triton (wash buffer)
(total sites sample) and (b) wash buffer containing an excess of
unlabeled a-BuTx (outside sites sample). After 30-min further
incubation, 0.1-ml aliquots were applied to Whatman DE-81
discs andwashed for 30 min in wash buffer, with three changes,
before counting in a Beckman Gamma-4000 gamma counter
(Beckman Instruments, Inc., Fullerton, Calif.) . The fraction of
outside-out (extracellular side out) vesicles was determined from
the ratio [outside sites counts]/[total sites counts] .
a-BuTx was purified from thevenom ofBungarusmulticinctus
by the method of Clark et al. (4). Triton-solubilized membrane
fragment proteins depleted in AcChR (MFTS-R) were prepared
by removing the AcChR from Triton-solubilized membrane
fragments on an a-BuTx affinity column, and were the gift of T .
Claudio .
Protein concentrations were determined by the method of
Lowry et al. (22) using bovine serum albumin as the standard.
The concentration of a-BuTx sites was determined according to
Schmidt and Raftery (36) using DEAE-cellulose filter discs and
...I-a-BuTx . SDS polyacrylamide gel electrophoresis was done
according to Laemmli (20), with a 12.5% acrylamide, 0.1% meth-
ylene-bis-acrylamide separating gel and a3% acrylamide, 0.08%
bis-acrylamide stacking gel . Immunodiffusion assays were con-
ducted according to Ouchterlony (25) .
Preparation ofAntibodies
Antibodies to Triton-solubilized, purified AcChR (anti-
AcChR) from T . californica were raised in New Zealand white
rabbits according to Claudioand Raftery (5) . The purity of the
AcChR was checked on SDS gels before injection, with pure
AcChR defined as the complex consisting of only the four
polypeptide chains previously described (16, 29) . Over a period
of 2 yr, six different rabbits were injected with several different
AcChR preparations (see Table I) ; only two of the rabbits (Nos.
5 and 6) received the same AcChR preparation. 0.5-1 mg of
AcChR emulsified in Freund's complete adjuvant was injected
subcutaneously at multiple sites along the back . 1-2 wk after
boosting, all but one ofthe rabbits displayed the paralysis symp-
tomatic of experimental autoimmune myasthenia gravis
(EAMG) (26) and were bled to death . Rabbit No . 2, despite
repeated injections, never showed symptoms of the disease ; 40
ml of blood was obtained from an ear vein weekly for 2wk after
each challenge of this rabbit . Antibodies to a-BuTx were pre-
pared following the same injection schedule, using 0.1 mg a-
BuTx emulsified in Freund's complete adjuvant per injection.
The immunoglobulin fraction of antisera (Ig) was prepared by
two fractionations with ammonium sulfate (0-33%), and the
pellets were dialyzed against phosphate-buffered saline (PBS).
This immunoglobulin fraction was clarified by centrifugation at
15,000 g for 30 min before dilution into NPE for the labeling
experiments. Normal rabbit Ig (NRG)was prepared by ammo-nium sulfate fractionation of pre-immune serum . Antibody titers
were determined by the method of Claudio and Raftery (manu-
script in preparation). Triton-solubilized, purified AcChR, bound
to ...I-a-BuTx, was incubated with the Ig fraction of the anti-
AcChR serum at room temperature . After l h, enough Staphy-
lococcus aureus to precipitate all the IgG was added and incu-
bated for 30 min. The solution was centrifuged at 15,000 g for 5
min, and the pellet was washed in 10 mM Na-phosphate, 0.1%
Triton, and counted on a Beckman Gamma-4000 gamma
counter.
Hemocyanin-Protein A conjugate (Hcy/A) was prepared by
the method of Miller et al. (manuscript in preparation), using
glutaraldehyde as the cross-linking reagent . I ml of hemocyanin
(70 mg/ml), purified by centrifugation and get filtration from the
hemolymph of Busycon canaliculatum, and 1 ml of Protein A
(Pharmacia Inc., Piscataway,N. J . ; 3.6 mg/ml) were conjugated
with 0.22 ml of 0.5% glutaraldehyde . After 45 min at room
temperature, 0.2 ml of2Mglycine wasadded to bind unreacted
glutaraldehyde . After 15 min at room temperature, the solution
was dialyzed for 24 h at 4°C against PBS, and the Hcy/A
conjugate was separated fromunconjugated ProteinAby passage
over a Sepharose 2B column.
Labeling of Intact and Broken Vesicles
with Antibodies
INTACT VESICLE LABELING :
￿
To attach intact vesicles to
cover slips, the glass cover slips were first treated with I% Alcian
Blue (39) for 15 min and washed three times in NPE . 50 MI of
intact vesicles (2 mg/ml) were incubated on the cover slip for 15
min, and the excess membranes were rinsed off with NPE . For
identification of AcChR antigenic determinants, 35 td of anti-
AcChR Ig from each of the six rabbits (0 .5 mg/ml) were then
incubated on the cover slip for 30 min at room temperature . The
cover slip was then rinsed three times in NPE, and treated with
Hcy/A as described below. BuTx-binding sites were visualized
by incubation of the cover slip in a-BuTx (0.02 mg/ml) for 45
min before treatment with anti-BuTx Ig and Hcy/A . Control
experiments were done by substituting NRG for immune anti-
bodies.
CYTOPLASMIC MEMBRANE LABELING :
￿
Toexposethecy-
toplasmic face of the vesicles, a modification of the method of
Jacobson and Branton (14) wasused . Thecoverslip wasclamped
between two pieces ofplexiglass with a hole exposingmost ofthe
surface of the cover slip. This apparatus was suspended in l liter
of cold NPE and sonicated in a bath sonicator (Laboratory
Supplies Co ., Inc., Hicksville, N . Y.) at 80 kHz for 5 min . The
cover slip was then removed and labeled with antibodies as
described above.
HCY/A LABELING OF IMMUNOLABELED VESICLES :
After labeling with immune or pre-immune antibodies, the cover
slips containing intact or sonicated vesicles were incubated with
Hcy/A (1 .5 mg/ml in NPE) for 30 min at room temperature and
washed three times inNPE .
Preparation of Samplesfor
Electron Microscopy
TABLE I
Characterization ofAnti-AcChR Antisera
Immediately after labeling with Hcy/A, samples were fixed
in 1% glutaraldehyde in NPE for several hours, followed by
fixation in 1% OS04 in half-strength NPE for 1 h at 4°C . After
dehydration in a graded series of ethanol solutions, the samples
were dried at the critical point using COz as the transition fluid
in a Polaron apparatus (Polaron Instruments Inc., Line Lexing-
ton, Pa .). The cover slips were shadowed at a 45° angle with
platinum/palladium followed by coating with carbon at a 90°
angle in a vacuum evaporator. Replicas were then separated
from the glass cover slip by etching with 48% hydrofluoric acid,
and the membrane fragments were removed with twice-filtered
household bleach . After rinsing with water, the replicas were
deposited on copper grids and examined in a Philips 201 electron
microscope .
RESULTS
The intact vesicles described here were from 94 to
100% extracellular side-out, i.e ., 94-100% of the
total a-BuTx sites were exposed on the outside
surface of the vesicles, as determined by the a-
BuTx binding assay described in Materials and
Methods . When examined at the electron micro-
scope level, replicas ofthese preparations consisted
of spherical vesicles ranging in diameter from 0.1
to 1 Am (see Fig . 1 a) . Upon sonication for 5 min,
the vesicles appeared as flat circles with a rough
texture, often with a thickening at the perimeter
attributable to edges not attached to the Alcian-
blue coating (Fig . 1 e) . A time-course of the effects
* Titers are given per milliliter ofserum .
$ Ouchterlony results are as judged visually, with ++++ indicating a very strong reaction,+ a very weak reaction,
and- no reaction .
§These two rabbits were injected with the same preparation ofAcChR.
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Titers* Ouchterlony reactions* EM studies with Hcy/A
Rabbit No.
Contracted
EAMG
nmol a-BuTx
sites pmol AcChR AcChR MFTS MFTS-R
Extracellular
labeling
Cytoplasmic
labeling
1 yes 0.32 2.00 ++++ - yes no
2 no 0.51 3.00 ++++ ++ yes no
3 yes 0.65 4.06 ++++ - yes no
4 yes 0.54 3.37 ++++ + yes no
5§ yes 1.95 12.17 ++++ - yes yes
6§ yes 2.35 14.16 ++++ - yes no502
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maintained intact their spherical shape, while by
5 min -95% of the vesicles had been sheared,
leaving their inside faces exposed. At times longer
than 10 min vesicles were frequently totally re-
moved from the Alcian blue, and after 30 min the
Alcian blue began to pucker and detach . Occa-
sionally, vesicles could be found which had col-
lapsed during sonication andwere not sheared off .
Such collapsed vesicles could be readily distin-
guished from sheared vesicles in both labeled and
unlabeled preparations by the smoother andmore
three-dimensional appearance of the former (see
Fig . 1) .
The binding of anti-AcChR and anti-BuTx Ig
to intact and sheared vesicles is summarized in
Tables II and 111 . That the intact vesicles were
oriented mainly so that their extracellular, a-
BuTx-binding side faced outward was verified at
the electron microscope level by the binding of
a-BuTx and anti-BuTx Ig, visualized with the
Hcy/A marker . As can be seen in Fig . 2 a, the
outsides of several vesicles treated with a-BuTx
and anti-BuTx Ig, visualized with Hcy/A, were
coated with the Hcy/A markers. Upon sonication,
the inside surfaces of the vesicles were exposed but
no a-BuTx binding could be discerned (Fig . 2b) .
Controlexperiments in which vesicles were treated
with NRG and Hcy/A showed no labeling on
either the intact or the sonicated vesicles (Fig . 3).
With all six anti-AcChR Ig preparations, the ex-
tracellular faces of the membranes were labeled
(Fig . 4a). With both anti-BuTx and anti-AcChR
Ig's, a high proportion (70-80%) of the larger
intact vesicles (-0.5 pm in diameter and larger)
were heavily labeled, while most of the smaller
vesicles and some of the larger ones were not
labeled at all with either antibody .
When the sonicated vesicles were treated with
anti-AcChR Ig, there was a dramatic difference in
labeling from one antibody preparation to the
next . With anti-AcChR Ig's from rabbits Nos . 1,
2, 3, 4, and 6, therewas little if any labeling on the
insides of the vesicles (Fig . 46). Occasionally,
inside labeling of the vesicles was observed (Fig .
4c), but it was usually sparse and could be corre-
lated with an increase in the background labeling
of the Alcian blue, suggesting that insufficient
washing may have caused nonspecific disposition
of Hcy/A on the vesicle surface . In other cases
(Fig . 4d), label was observed only around free
edges of the vesicle which had curled over and
faced upward, exposing a narrow rim of external
AcChR sites to the anti-AcChR Ig solution .
With anti-AcChR Ig from rabbit No . 5, soni-
cated vesicles were heavily labeled (Fig . 4 e) . The
density ofHcy/A markers on the vesicles was up
to 15 times higher than that on the Alcian-blue
background, an increase comparable to that ob-
served in the labeling of intact vesicles with anti-
AcChR Ig (compare Fig . 4a and e) . As in the
labeling of intact vesicles, it was mainly the larger
sonicated vesicles that were labeled with anti-
AcChR Ig from rabbit No . 5 ; most of the smaller
vesicles and some of the larger ones did not label
at all (Fig . 4f).
The labeling results are summarized in Tables
II and III . All vesicles in large fields (each con-
taining -200 vesicles) ofintact or sheared vesicles
treated with each of the anti-AcChR preparations,
a-BuTx +anti-BuTx, orNRG were examined and
the percentage of vesicles labeled with Hcy/A
FIGURE 1
￿
(a)Two intact Torpedo electroplaque membrane vesicles, with the extracellular side (E) ofthe
synaptic membrane exposed. The vesicles are smooth and spherical . x60,000 . (b) An intact vesicle,
extracellular side (E) exposed, labeled with anti-AcChR and Hcy/A . The spherical shape of the vesicle
can be distinguished beneath the hemocyanin markers (h) . x50,000 . (c)Adeflated membrane vesicle (D),
with its extracellular side exposed, appears as asmooth but flat circle . x 43,000 . (d) A deflated vesicle (D),
labeled with anti-AcChR and Hcy/A . The smooth surface of the vesicle can be seen beneath the
hemocyanin markers (h) . (e) Membrane vesicles after 5-min sonication . The vesicles have been sheared,
leaving the rough cytoplasmic face (C) of the membrane exposed . A thickening around the rim of the
vesicle (r) can be attributed to membrane not attached to the Alcian blue. These vesicles can be readily
distinguished from deflated vesicles (Fig. 1 c) by the roughness of the cytoplasmic face . x 68,000. (f) A
sheared membrane vesicle after 5-min sonication, labeled with anti-AcChR from rabbit No. 5 and Hcy/
A. The rough, cytoplasmic face of the membrane (C) can be identified beneath the hemocyanin markers
(h). These sheared, labeled vesicles canbe easily distinguished from intact, labeled vesicles and deflated,
labeled vesicles, as can be seen by a comparison of b, d, andf x 50,000 .
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Antibody Labeling of Vesicles in a Single Field, According to Size
TABLE II, SUMMARY
All vesicles in a single field were counted for each antibody category and the percentage oflabeled vesicles for each
size range determined . The results are summarized in the lower half ofthe table .
TABLE III
Antibody Labeling ofIntact and Sheared Vesicles
504
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Vesicle diameter
Vesicle prep-
Antibody preparation aration
=5,000
No . la-
beled/to-
tal
A
% La-
beled
3,000-5,000 A
No . la- % La-
beled/total beled
1,000-3,000 A
No. la- % La-
beled/total beled
!_1,000
No. la-
beled/total
A
% La-
beled
Anti-AcChR No . I Intact 5/7 71 11/36 31 3/152 2 0/72 0
sheared 0/3 0 1/6 17 0/30 0 0/22 0
Anti-AcChR No . 2 Intact 7/13 54 14/40 35 3/106 3 0/66 0
sheared 0/3 0 0/10 0 0/51 0 0/120 0
Anti-AcChR No . 3 Intact 7/8 88 10/42 24 6/147 4 0/73 0
sheared 0/2 0 0/10 0 0/22 0 0/92 0
Anti-AcChR No . 4 Intact 8/11 73 9/31 29 6/116 3 0/89 0
sheared 0/4 0 1/12 8 1/11 9 0/43 0
Anti-AcChR No . 5 Intact 5/7 71 7/24 29 6/163 2 0/70 0
sheared 5/6 83 10/38 26 3/45 7 0/78 0
Anti-AcChR No . 6 Intact 4/5 80 10/40 25 5/152 3 0/87 0
sheared 0/3 0 1/34 3 3/47 6 0/49 0
Anti-BuTx Intact 4/5 80 8/36 22 2/108 2 0/95 0
sheared 0/2 0 0/21 0 0/26 0 0/92 0
NRG Intact 0/10 0 0/52 0 0/104 0 0/83 0
sheared 0/8 0 0/12 0 0/27 0 0/17 0
Vesicle diameter
Antibody
?5,000 A
No . labeled/total % Labeled
3,000-5,000 A
No. labeled/total % Labeled
(A) Extracellular surface labeling
Anti-AcChR Nos. 1-6 56/73 77 ± 9 54/189 29 ± 4
Anti-BuTx 35/49 71 ± 9 11/49 22 ± 3
NRG 0/52 0 0/52 0
(B) Cytoplasmic surface labeling
Anti-AcChR Nos . 1-4,6 2/58 3 ± 3 3/78 4 ± 3
Anti-AcChr No . 5 39/50 78 t 10 13/51 25 ± 3
Anti-BuTx 2/52 4 t 3 1/57 2 ± 2
NRG 0/51 0 0/42 0
(A) Extracellular surface labeling (% labeled) (B) Cytoplasmic surface labeling(% labeled)
Vesicle
diameter
Antibody~ ?-5000 A
3,00~
5,000 A
1,000-
3,000 A
!_1,000
A
\ Vesicle
Antibod`
diameter
5,000 A
3,000-
5,000 A
1,000-
3,000 A
l1,000
A
Anti-AcChR 73 ± 9 29 ± 4 3 ± 0 .8 0 Anti-AcChR 0 6 ± 7 3 ± 4 0
No . 1-6 Nos. 1-4,6
Anti-BuTx 80 ± 10 22 ± 3 2 ± 0 .5 0 Anti-AcChR 83 ± 10 26 ± 4 7 ± 7 0
No. 5
NRG 0 0 0 0 Anti-BuTx 0 0 0 0
NRG 0 0 0 0FIGURE 2
￿
Vesicles treated with a-BuTx followed by anti-BuTx and Hcy/A. (a) Hemocyanin molecules
(h) can be seen as round or square particles on the external surface (E) of the larger intact vesicles . The
small vesicles are not labeled and are probably lipid vesicles . A deflated vesicle (D)can be identified by
its distinctive shape and smoothness. x 31,000. (b) After sonication, the vesicles are sheared, exposing
their cytoplasmic sides (C). Hemocyanin molecules (h) appear in the background, but only one can be
detected at the edge of a vesicle. x 49,500 .
FIGURE 3
￿
Control experiment in which vesicles were treated with pre-immune rabbit Ig and Hcy/A . (a)
With intact vesicles there was no labeling of the extracellular side of the membrane (E) . x 50,000. (b)
After sonication, the cytoplasmic side of the membrane (C) was exposed and did not label . x81,000.506
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?5,000; 3,000-5,000 ; 1,000-3,000 ; and !_1,000 A)
was determined. As is clear from Table II, the
AcChR-containing vesicles are essentially all
larger than 3,000 A in diameter, with 70-80% of
the intact vesicles larger than 5,000 A and 20-30%
of those in the 3,000-5,000 A range containing
AcChR, as determined by Hcy/A visualization of
both anti-AcChR and a-BuTx + anti-BuTxbind-
ing . To provide a better statistical sample from
which to determine whether anti-AcChR from
rabbit No . 5 did indeed consistently label the
insides of AcChR-containing vesicles, 40 or more
vesicles with diametersof 3,000-5,000 A and40 or
more with diameters?5,000 A were examined for
Hcy/A labeling after treatment with anti-AcChR,
a-BuTx + anti-BuTx, or pre-immune Ig. Anti-
AcChR from rabbits Nos. 1-4 and 6 and anti-
BuTx behaved the same way, again labeling 70-
80% of the largest vesicles and 20-30% of the
3,000- to 5,000-A vesicles on the extracellular side
of the membrane and essentially none on the
cytoplasmic side. This larger sampling also con-
firmed the result indicated in the smallersampling
in Table II : anti-AcChR from rabbitNo . 5 labeled
the cytoplasmic side of the membranes on 78% of
the ?5,000-A vesicles and 25% of the 3,000- to
5,000-A vesicles, the same amount of labeling
observed on the extracellular sidesofthese vesicles
with a-BuTx + anti-BuTx and with all six anti-
AcChR preparations (including that from rabbit
No . 5) . Pre-immune Ig labeled on neither the
insides nor the outsides of vesicles in any size
range.
Ouchterlony immunodiffusion assays of each
anti-AcChR Ig preparation against purified
AcChR, Triton-solubilized membrane fragments
(MFTS), and MFTS-R showed a strong reaction
of all anti-AcChR Ig against AcChR and against
MFTS (see Fig . 5) . Only one preparation (from
rabbitNo . 2) reacted moderately with the MFTS-
R (see Table I) . With one other anti-AcChR Ig
preparation, a barely discernible reaction was re-
corded. With the other four anti-AcChR Ig prep-
arations (including that from rabbit No. 5), no
reaction with the MFTS-R was observed .
DISCUSSION
The experimental evidence presented here indi-
cates that the AcChR, composed of four subunits
with mol wt of 40,000, 50,000, 60,000, and 65,000
(16, 28, 29), is a transmembrane protein. The
method of immunospecific labeling used permits
complete exposure of both the extracellular and
the cytoplasmic faces of the membrane to the
antibody solution . These faces could be clearly
identified as the extracellular face of the synapse
corresponding to the outside face ofthe membrane
vesicle and the cytoplasmic face to the inside of
the vesicle by Hcy/A visualization of the binding
of a-BuTx and anti-BuTx . Hemocyanin has
proven to be a highly visible marker in TEM
studies of smooth cellular or membrane surfaces
(2, 37), and the specificity of Hcy/A for IgG,
already established by Miller et al. (manuscript in
preparation), is here shown again by the lack of
labeling with NRG. The use of osmotically intact
vesicles permitted theuse of a 125I-a-BuTx binding
assay to confirm that most of the vesicles were
indeed "right-side out," i.e., most of the a-BuTx
sites were exposed on the outside surface of the
vesicles, in agreement with the observations of
Hartig and Raftery (12) .
In the labeling of intact vesicles with anti-
AcChR Ig, the results obtained with antisera from
different rabbits were in excellent agreement . An-
FIGURE 4
￿
Vesicles treated with anti-AcChR followed by Hcy/A . (a) Intact vesicles treated with any of
the six anti-AcChR preparations were labeled with hemocyanin (h) on their external surfaces. As in Fig .
2, most of the larger vesicles were labeled, while the smaller ones were not. x31,000 . (b-d) Vesicles after
sonication, treated with anti-AcChR from rabbit No . 1, 2, 3, 4, or 6 . (b) Few hemocyanin molecules (h)
can be seen on the cytoplasmic side of the membrane or on the background . x 37,000 . (c) An increase in
the hemocyanin (h) labeling of the cytoplasmic membranes corresponds to an increase in the hemocyanin
in the background . x43,000 . (d) The cytoplasmic face (C) of the sheared vesicle can be seen with
thickening around the free edges (r) . The entire rim is labeled with hemocyanin molecules (h), with none
in the center . x 66,000. (e andf) Vesicles after sonication, treated with anti-AcChR from rabbit No . 5 . (e)
A close-up of one vesicle shows the characteristic rough cytoplasmic side of themembrane heavily labeled
with hemocyanin (h) . x47,000 . (f) A view of a larger field shows sheared vesicles with their cytoplasmic
sides exposed. (L) A large vesicle is labeled with hemocyanin (h), while several smaller vesicles are
unlabeled (U) . x 22,000.
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numbers 1-6 indicate the wells which were filled with
anti-AcChR Ig from rabbits 1-6 . The antigens in the
centerwells were (a) AcChR, (b) MFTS, and (c) MFTS-
R. The arrow points out the faint cross-reaction observed
betweenMFTS-R and Ig from rabbit No . 2 .
tisera from all rabbits showed equal labeling of
the outside (extracellular) faces of intact vesicles .
The observation that the same proportion of vesi-
cles of each size range was labeled with both anti-
BuTx and anti-AcChR Ig is indicative of the
specificity of the antibodies for the AcChR since
it indicates that the same vesicles were labeled
with both reagents . The differences in labeling
from one antibody preparation to the next became
apparent only in the labeling of the cytoplasmic
faces of sonicated vesicles, where anti-BuTx and
five ofthe six preparations ofanti-AcChR showed
little or no labeling and one showed labeling com-
parable to that seen on the extracellular face of the
membranes .
That the labeling seen with anti-AcChR from
rabbit No . 5 was specific labeling of the AcChR
on the cytoplasmic face of the membrane was the
conclusion drawn from several lines of evidence .
(a) The AcChR injected into the rabbit producing
these antibodies was highly purified as judged by
its SDS gel electrophoresis profile, having a gel
pattern consistent with that of pure T . californica
AcChR (16, 28, 29). Furthermore, the same
AcChR preparation was injected at the same time
into another rabbit (No . 6) whose antisera were
also used in these studies . The antibodies from
rabbit No. 6 did not react with the cytoplasmic
sides of the vesicles, ruling out the possibility that
there was simply a variation in the AcChR prep-
aration used to immunize the rabbit which caused
this labeling of the cytoplasmic face . (b) The im-
munodiffusion results indicate that it is in all
likelihood not a contaminant in the AcChR in-
jected into the rabbit that causes labeling of the
cytoplasmic face with the antibodies from rabbit
No . 5 . In the interaction between the various anti-
AcChR Ig preparations and MFTS-R, there was
no discernible reaction with immunoglobulins
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from rabbit No . 5 . There was, however, a very
faint reaction with the antisera from rabbit No . 2
and a barely discernible reaction with antisera
from rabbit No . 4, neither of which labeled the
cytoplasmic face . (c) All labeling experiments were
repeated three times with three different intact
vesicle preparations, yielding the same results.
Therefore, the labeling of the cytoplasmic face of
the membrane by this anti-AcChR preparation
was a real phenomenon and not an artifact caused
by insufficient washing of one sample . (d) Finally,
the statistics of labeling given in Tables II and III
indicate that the AcChR-containing vesicles can
be identified by their large size . It is these large
vesicles that label with both anti-AcChR (77%)
and anti-BuTx (71%) on the extracellular face and
which also label with this anti-AcChR preparation
(78%) on the cytoplasmic face . This statistical
agreement also holds for vesicles in the 3,000- to
5,000-A range, 20-30% of which contain AcChR .
That none ofthe vesicles labeled with pre-immune
Ig on either sidè nor with a-BuTx + anti-BuTx on
the cytoplasmic side also indicates that the labeling
observed is specific for the given antibody-antigen
interaction .
It is not unusual that different rabbits injected
with the same antigen would produce antibodies
ofdiffering specificities; these experimental rabbits
are outbred population and their immune re-
sponses are not homogeneous . Such differences in
the specificities of rabbit antibodies have been
found in studies of the functional effects of anti-
AcChR antibodies (15, 33) and of anti-Na',K+ -
ATPase antibodies (19) . That only one out of six
rabbits displayed an immune response to antigens
on the inside face ofthe membrane indicates either
that the portion of the receptor exposed on this
side is not very antigenic and/or that only a small
portion of the molecule is exposed on the cyto-
plasmic face. This concurs with the findings of
Ross et al . (32), who determined that protein
protruded only 15 ± 5 A on one side of the
membrane of AcChR-enriched preparations while
extending 55 ± 5A from the other side .
In thin-section electron micrographs of the la-
beling of membrane-fragments in solution with
ferritin-conjugated anti-AcChR antibodies, Tar-
rab-Hazdai et al. (40) saw some labeling of both
sides ofopen vesicles, while Karlin et al . (15) saw
some inside labeling, but were unable to distin-
guish it from nonspecific sticking of ferritin. This
difference may also have resulted from differing
specificities of the anti-AcChR antibody prepara-tions used . In the labeling of whole vesicles with
antibody molecules, the insides are often not ac-
cessible to the labeling reagents (40 ; C.D. Strader,
unpublished observations) and there can be non-
specific trapping of labels inside the vesicles . Pre-
liminary observations both by electron microscopy
(C . D. Strader, unpublished observations) and by
flux measurements (H.-P. Moore and P. Hartig,
unpublished observations) indicate that Torpedo
membrane vesicles reseal after osmotic shock, thus
complicating this experimental approach . The la-
beling method described here avoids any ambi-
guities caused by inaccessibility or by trapping of
label inside the vesicles, since only the extracellu-
lar side or only the cytopasmic side of the mem-
brane is completely exposed to the labeling solu-
tion .
The AcChR consists of four subunits of mot wt
40,000, 50,000, 60,000, and 65,000 daltons (16, 28,
29) . By lactoperoxidase-catalyzed iodination of the
outsides of intact vesicles, Hartig and Raftery
(manuscript in preparation) have shown that por-
tionsofall four oftheAcChRsubunits areexposed
on the extracellular face of the synaptic mem-
brane . Lindstrom et al. (21) have shown that an-
tibodies to each of the AcChRsubunits cross-react
with rat muscle receptors in vivo, causing a de-
crease in muscle AcChR content . Hence, each of
these four polypeptide chains must contain at least
some antigenic determinants exposed on the extra-
cellular face of the membrane.
Attempts to label the membrane vesicles with
antibodies to individual AcChR subunits have
been unsuccessful . This is probably due to the
failure of such antibodies (prepared against the
denatured individual subunits isolated from pre-
parative SDS polyacrylamide gels) to react with
native,membrane-boundAcChRas observed with
electron microscopy. Therefore, it was not possible
to determineby this method whichofthe subunits
areexposed on the extracellular side and whichon
the cytoplasmic side of the membrane .
In conclusion, we have developed an unambig-
uous method for immunospecific labeling of the
extracellular face or of the cytoplasmic face of
membrane vesicles enriched in AcChR . The
AcChR is a complex molecule consisting of four
polypeptide subunits which remain together as a
complex in the presence ofTriton (35) andcholate
(Elliott et al ., manuscript in preparation) and
which dissociate only when denatured in SDS
(29) . Antibodies to the AcChR containing only
these four subunits were prepared and used to
label a preparation of vesicles (12) in which 94-
100% of the a-BuTx-binding sites were on the
outside surface of the membrane . Thus, in these
vesicles, almost all of the AcChR molecules were
at least partially exposed to the outside surface of
the vesicles (corresponding to the extracellular face
of the postsynaptic membrane) . All preparations
of anti-AcChR antibodies were found to bind to
the outer surface of the vesicles, and one prepa-
ration also bound to the inner surface of the
vesicles. Therefore, one or more of the four poly-
peptide subunits ofthe AcChRused as the antigen
for production of these antibodies is exposed on
the extracellular face of the membrane, and one
or more is exposed on the cytoplasmic face ofthe
membrane. Thus, it may be concluded from this
evidence that the AcChR is a transmembrane
protein, with many antigenic determinants on the
extracellular face of the synaptic membrane and
with few of the antigenic determinants protruding
on the cytoplasmic face of the membrane .
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